2. Signaling Pathways
  3. Antibody-drug Conjugate/ADC Related
  4. Radionuclide-Drug Conjugates (RDCs)
  5. Radionuclide-Drug Conjugates (RDCs) Control

Radionuclide-Drug Conjugates (RDCs) Control

Radionuclide-Drug Conjugates (RDCs) Isoform Comparison

Radionuclide-Drug Conjugates (RDCs) Controls (2):

Cat. No. Product Name Effect Purity
  • HY-114377
    p-SCN-Bn-DOTA
    		Control 99.75%
    p-SCN-Bn-DOTA is a bifunctional chelating agent. p-SCN-Bn-DOTA can simultaneously chelate radionuclides and link monoclonal antibody for radioimmunoresearch of tumor.
  • HY-164654
    DOTA-PEG10-azide
    		Control
    DOTA-PEG10-azide is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy.